Marksans Pharma Ltd.
| BSE: 524404 | Sector: Health care |
| NSE: MARKSANS | ISIN Code: INE750C01026 |
| BSE 00:00 | 23 Jul | 86.40 |
-0.40 (-0.46%) |
OPEN
87.25 |
HIGH
87.50 |
LOW
86.00 |
| NSE 00:00 | 23 Jul | 86.40 |
-0.35 (-0.40%) |
OPEN
87.00 |
HIGH
87.45 |
LOW
86.05 |
| OPEN | 87.25 |
| PREVIOUS CLOSE | 86.80 |
| VOLUME | 315092 |
| 52-Week high | 97.50 |
| 52-Week low | 34.10 |
| P/E | 36.00 |
| Mkt Cap.(Rs cr) | 3,536 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Marksans Pharma Ltd. (MARKSANS) - Company Information
Marksans Pharma Ltd
Marksans Pharma Limited is a public limited company incorporated in the year April 16th 1982. The Company is primarily engaged in the business of research manufacture marketing and sale of pharmaceutical formulation. The Company's research and development facilities are located in Verna Goa and R & D center in Navi Mumbai.The Company on 30th March 2015 issued and allotted 24006494 equity shares of...> More
| COMPANY INFORMATION | |||||||
| Chairman & Managing Director : | Mark Saldanha | ||||||
| Company Secretary : | Harshavardhan Panigrahi | ||||||
| Non-Exec. & Independent Dir. : | Seetharama Raju Buddharaju | ||||||
| Whole-time Director : | Sandra Saldanha | ||||||
| Non-Exec. & Independent Dir. : | Digant Mahesh Parikh | ||||||
| Whole-time Director : | Varddhman Vikramaditya Jain | ||||||
| Non-Exec. & Independent Dir. : | Abhinna Sundar Mohanty | ||||||
| Addtnl Independent Director : | Meena Rani Surana | ||||||
| AUDITOR : | Bhuta Shah & Co LLP | ||||||
| IND NAME : | Pharmaceuticals - Indian - Bulk Drugs | ||||||
| HOUSE NAME : | Indian Private | ||||||
| Registered office | |||||||
| 11th Flr GRANDEUR Oshiwara, Veera Desai Extn Rd Andheri(W),Mumbai,Maharashtra-400053 | |||||||
| Ph : 91-22-40012000 | |||||||
| WEBSITE : http://www.marksanspharma.com | |||||||
| E-mail : companysecretary@marksanspharma.com | |||||||
Quick Links for Marksans Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
